2023Q1营收大幅下滑59.4%,营业利润下滑94.6%,净利润几乎归零。
目前市盈率8.5,市盈率TTM已经飙升到23.4,可以多看几个季度再做判断。查看全文
$ProPhase Labs, Inc.(PRPH)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-06-25 AccNo: 0001493152-18-009178 Size: 330 KB 网页链接
$ProPhase Labs, Inc.(PRPH)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-06-07 AccNo: 0001493152-18-008330 Size: 127 KB 网页链接
$ProPhase Labs, Inc.(PRPH)$ 8-K - Current report Filed: 2018-05-24 AccNo: 0001493152-18-007766 Size: 206 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Su...
$ProPhase Labs, Inc.(PRPH)$ 内部交易: 2018-05-15,CEO & CHAIRMAN,Karkus Ted William ,期权,250000普通股, $1.86
$ProPhase Labs, Inc.(PRPH)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-15 AccNo: 0001493152-18-007006 Size: 3 MB 网页链接
$ProPhase Labs, Inc.(PRPH)$ 8-K - Current report Filed: 2018-05-15 AccNo: 0001493152-18-006906 Size: 125 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$ProPhase Labs, Inc.(PRPH)$ 8-K - Current report Filed: 2018-05-08 AccNo: 0001493152-18-006377 Size: 67 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 8.01: Oth...
$ProPhase Labs, Inc.(PRPH)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-04-20 AccNo: 0001493152-18-005546 Size: 116 KB 网页链接
$ProPhase Labs, Inc.(PRPH)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-04-20 AccNo: 0001493152-18-005546 Size: 116 KB 网页链接
$ProPhase Labs, Inc.(PRPH)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-19 AccNo: 0001493152-18-005427 Size: 1 MB 网页链接